121 related articles for article (PubMed ID: 663972)
1. Identifications of 5 beta-cholestane-3 alpha, 7 alpha, 12 alpha, 23 beta-tetrol, 5 beta-cholestane-3 alpha, 7 alpha, 12 alpha, 24 alpha-tetrol, and 5 beta-cholestane-3 alpha, 7 alpha, 12 alpha, 24 beta-tetrol in cerebrotendinous xanthomatosis.
Yasuhara M; Kuramoto T; Hoshita T; Itoga E; Kito S
Steroids; 1978 Mar; 31(3):333-45. PubMed ID: 663972
[TBL] [Abstract][Full Text] [Related]
2. Bile alcohol profiles in bile, urine, and feces of a patient with cerebrotendinous xanthomatosis.
Shimazu K; Kuwabara M; Yoshii M; Kihira K; Takeuchi H; Nakano I; Ozawa S; Onuki M; Hatta Y; Hoshita T
J Biochem; 1986 Feb; 99(2):477-83. PubMed ID: 3700361
[TBL] [Abstract][Full Text] [Related]
3. Determination of the glucurono-conjugated position in bile alcohol glucuronides present in a patient with cerebrotendinous xanthomatosis.
Kuramoto T; Suemura Y; Kihira K; Hiraoka T; Hoshita T
Steroids; 1995 Oct; 60(10):709-12. PubMed ID: 8539780
[TBL] [Abstract][Full Text] [Related]
4. Occurrence of bile alcohol glucuronides in bile of patients with cerebrotendinous xanthomatosis.
Hoshita T; Yasuhara M; Une M; Kibe A; Itoga E; Kito S; Kuramoto T
J Lipid Res; 1980 Nov; 21(8):1015-21. PubMed ID: 7462799
[TBL] [Abstract][Full Text] [Related]
5. Absolute configuration at carbon 23 of 5 beta-cholestane-3 alpha,7 alpha,12 alpha,23,25-pentol excreted by patients with cerebrotendinous xanthomatosis.
Kihira K; Kubota A; Hoshita T
J Lipid Res; 1984 Aug; 25(8):871-5. PubMed ID: 6491531
[TBL] [Abstract][Full Text] [Related]
6. Increased plasma bile alcohol glucuronides in patients with cerebrotendinous xanthomatosis: effect of chenodeoxycholic acid.
Batta AK; Salen G; Shefer S; Tint GS; Batta M
J Lipid Res; 1987 Aug; 28(8):1006-12. PubMed ID: 3668385
[TBL] [Abstract][Full Text] [Related]
7. Effect of chenodeoxycholic acid on biliary and urinary bile acids and bile alcohols in cerebrotendinous xanthomatosis; monitoring by high performance liquid chromatography.
Batta AK; Shefer S; Batta M; Salen G
J Lipid Res; 1985 Jun; 26(6):690-8. PubMed ID: 4031647
[TBL] [Abstract][Full Text] [Related]
8. Identification of 5 beta-cholestane-3 alpha, 7 alpha, 12 alpha, 25, 26-pentol in cerebrotendinous xanthomatosis.
Dayal B; Tint GS; Greeley DN; Williams TH; Salen G
Steroids; 1983 Oct; 42(4):441-8. PubMed ID: 6679948
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and structure of 26 (or 27)-nor-5 beta-cholestane-3 alpha,7 alpha,12 alpha,24S,25 xi-pentol isolated from the urine and feces of a patient with sitosterolemia and xanthomatosis.
Dayal B; Tint GS; Toome V; Batta AK; Shefer S; Salen G
J Lipid Res; 1985 Mar; 26(3):298-305. PubMed ID: 2985722
[TBL] [Abstract][Full Text] [Related]
10. Bile alcohol glucuronides: regioselective O-glucuronidation of 5 beta-cholestane-3 alpha,7 alpha,12 alpha,25-tetrol and 24-nor-5 beta-cholestane-3 alpha,7 alpha,12 alpha,25-tetrol.
Dayal B; Salen G; Padia J; Shefer S; Tint GS; Sasso G; Williams TH
Carbohydr Res; 1993 Feb; 240():133-42. PubMed ID: 8458007
[TBL] [Abstract][Full Text] [Related]
11. Identification of new bile alcohols, 5 beta-cholestane-3 alpha,7 alpha,24,26-tetrol, 5 beta-cholestane-3 alpha,7 alpha,25,26-tetrol, and 5 beta-cholestane-3 alpha,7 alpha,26,27-tetrol in human gallbladder bile.
Une M; Shinonaga Y; Matoba N; Kuroki S; Kihira K; Hoshita T
J Lipid Res; 1986 Dec; 27(12):1318-23. PubMed ID: 3559394
[TBL] [Abstract][Full Text] [Related]
12. Cholic acid biosynthesis: the enzymatic defect in cerebrotendinous xanthomatosis.
Salen G; Shefer S; Cheng FW; Dayal B; Batta AK; Tint GS
J Clin Invest; 1979 Jan; 63(1):38-44. PubMed ID: 762246
[TBL] [Abstract][Full Text] [Related]
13. Identification of bile alcohols in human bile.
Kuroki S; Shimazu K; Kuwabara M; Une M; Kihira K; Kuramoto T; Hoshita T
J Lipid Res; 1985 Feb; 26(2):230-40. PubMed ID: 3989382
[TBL] [Abstract][Full Text] [Related]
14. Determination of the glucurono-conjugated position in bile alcohol glucuronides excreted in urine of a patient with cerebrotendinous xanthomatosis by a nuclear magnetic resonance study.
Kuramoto T; Fukuda K; Ohshima A; Kihira K; Hoshita T
J Biochem; 1994 Apr; 115(4):655-8. PubMed ID: 8089079
[TBL] [Abstract][Full Text] [Related]
15. Cerebrotendinous xanthomatosis: a defect in mitochondrial 26-hydroxylation required for normal biosynthesis of cholic acid.
Oftebro H; Björkhem I; Skrede S; Schreiner A; Pederson JI
J Clin Invest; 1980 Jun; 65(6):1418-30. PubMed ID: 7410549
[TBL] [Abstract][Full Text] [Related]
16. Bile alcohol metabolism in man. Conversion of 5beta-cholestane-3alpha, 7alpha,12alpha, 25-tetrol to cholic acid.
Salen G; Shefer S; Setoguchi T; Mosbach EH
J Clin Invest; 1975 Jul; 56(1):226-31. PubMed ID: 1141434
[TBL] [Abstract][Full Text] [Related]
17. Radioimmunoassay of 5 beta-cholestane-3 alpha,7 alpha,12 alpha,25-tetrol 3-glucuronide in serum of patients with cerebrotendinous xanthomatosis.
Une M; Kataoka J; Nakata Y; Hoshita T
Steroids; 1992 Jan; 57(1):32-6. PubMed ID: 1585391
[TBL] [Abstract][Full Text] [Related]
18. Cerebrotendinous xanthomatosis: a review of biochemical findings of the patient population in The Netherlands.
Koopman BJ; Wolthers BG; van der Molen JC; van der Slik W; Waterreus RJ; van Spreeken A
J Inherit Metab Dis; 1988; 11(1):56-75. PubMed ID: 3128689
[TBL] [Abstract][Full Text] [Related]
19. Metabolism of 5 beta-cholestane-3 alpha, 7 alpha, 12 alpha, 26-tetrol and 5 beta-cholestane-3 alpha, 7 alpha, 12 alpha, 25-tetrol into cholic acid in normal human subjects.
Hanson RF; Staples AB; Williams GC
J Lipid Res; 1979 May; 20(4):489-93. PubMed ID: 458268
[TBL] [Abstract][Full Text] [Related]
20. Configurational assignment of 5 beta-cholestane-3 alpha, 7 alpha, 12 alpha, 23, 25-pentol excreted by patients with cerebrotendinous xanthomatosis (a circular dichroism study).
Dayal B; Tint GS; Shefer S; Salen G
Steroids; 1979 Mar; 33(3):327-38. PubMed ID: 442127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
